SUMMARY To further evaluate thyroid function in patients with liver disease, we have measured total and free T3 and T4, thyroxine binding globulin, basal and thyrotropin releasing hormone-stimulated thyrotropin and thyroglobulin antibodies in 33 patients with liver cirrhosis, in 22 with chronic hepatitis and in 30 healthy controls. All the patients but one were clinically euthyroid. T3, FT3, T3/thyroxine binding globulin and T4/thyroxine binding globulin ratios and thyrotropin after thyrotropin releasing hormone were significantly reduced, while FM4, thyroxine binding globulin and thyrotropin were significantly increased in liver cirrhosis. In chronic hepatitis group, F13 and T3/thyroxine binding globulin ratio were significantly lower and thyroxine binding globulin and FT4 were higher than in healthy controls. The between patients comparison revealed a significantly lower T3, FT3, T3/thyroxine binding globulin and T4/ thyroxine binding globulin ratios and A thyrotropin in cirrhotics. Thyroglobulin antibodies were present at high titre only in two patients one of whom having evidence of Hashimoto's thyroiditis with subclinical hypothyroidism. The correlation coefficient between T4/thyroxine binding globulin ratio and FT4 were lower in patients than in controls. Furthermore an abnormal thyrotropin response to thyrotropin releasing hormone was shown in 10 cirrhotics and in four patients with chronic hepatitis. Serum T3 significantly correlated with serum bilirubin, albumin, and prothrombin time in both groups of patients. The present data confirm the existence of several abnormalities of thyroid function tests in patients with chronic liver disease, although showing that euthyroidism is almost always maintained, probably as a result of low-normal FT3 and high-normal FT4. Furthermore, T3 serum levels appear to parallel the severity of liver dysfunction. 
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The statistical analysis wa-rc.ried out using the Student's t test and linear correlation as appropriate. Data are expressed as mean±SF.
Results
The mean values for the different indices of thyroid function in the two groups of patients with liver disease and in normal controls are reported in Table  3 . Cirrhotic patients showed significantly reduced serum levels of T3, T3/thyroxine binding globulin ratio, FT3, T4/thyroxine binding globulin ratio and A thyrotropin and significantly increased levels of thyroxine binding globulin, FT4 and basal thyrotropin versus normals. Subjects with chronic hepatitis showed significantly lower T3/thyroxine binding globulin ratio and FT3 and higher thyroxine binding globulin and FT4 levels than in controls.
The comparison between the first and the second group of patients revealed that cirrhotics have significantly lower T3, T3/thyroxine binding globulin ratio, FT3, T4/thyroxine binding globulin ratio and A thyrotropin. Antithyroglobulin antibodies were absent in all patients, but one with chronic alcoholic hepatitis and one with cirrhosis in whom high titres were present (1:10 000); one of them (chronic alcoholic hepatitis) also had high serum thyrotropin concentrations (14 ,WU/ml) with exaggerated response to thyrotropin releasing hormone, with normal total and free T3 and T4, suggesting the coexistence of Hashimoto's thyroiditis and preclinical hypothyroidism. The results obtained with total and free T3 and T4 concentrations in the individual patients are shown in Figs. 1-3 . Low T3 values were observed in 18 cirrhotics and in two patients with chronic hepatitis. T4 was normal in all cases, except for five cirrhotics with low values and one subject for each group with slightly raised concentrations (Fig. 1) . FT3 was reduced in 18 cirrhotics and in four subjects with hepatitis ( Fig. 2) . FT4 was normal in all instances except two cases with low, and four with raised concentrations (Fig. 3) . Figure 4 shows that almost all patients with low FT3 had normal or sometimes raised FT4.
T3/thyroxine binding globulin and T4/thyroxine binding globulin ratios were significantly correlated with the actual FT3 and FT4 concentrations, respectively, both in subjects with cirrhosis and chronic hepatitis (Figs. 5, 6 ). While the correlation coefficient, however, between T3/thyroxine binding ---_* globulin ratio and FT3 was not different from that observed in normal controls (r=0.65, p<0.001), the coefficients between T4/thyroxine binding globulin ratio and FT4 were lower, particularly in cirrhotics, than that observed in normals, (r=0.82, p<0001). Basal serum thyrotropin concentrations above the normal range were found in two cirrhotic patients (6.5 and 7-8 ,uU/ml) and in the above mentioned subject with chronic hepatitis and Hashimoto's thyroiditis. The thyrotropin response to thyrotropin releasing hormone was normal in 23 and impaired in 10 patients with cirrhosis; among subjects with chronic hepatitis 18 had normal, two impaired and two exaggerated responses. The delayed pattern of thyrotropin response to thyrotropin releasing hormone -that is, 60 minute concentrations higher than 20 minute concentrations, was observed in eight cirrhotics. concentration was significantly correlated in both patient groups with serum bilirubin albumin, and prothrombin time, but not with transaminases.
Discussion
The existence of the so called low T3 syndromethat is, low total T3 with normal total T4 and thyrotropin concentrations in the absence of clinical hypothyroidism, has been frequently reported in patients with chronic liver disease as well as in many other non-thyroidal illnesses, 13 6 17 and it has been shown to depend on impaired liver conversion of T4 to T3.
Our data also confirm a highly significant reduction of T3 serum concentration in liver disease, the group.bmj.com on October 14, 2017 -Published by http://gut.bmj.com/ Downloaded from lowest values being found in cirrhotics, with generally normal total T4 and thyrotropin concentrations.
In a large group of alcoholic patients Israel et a19
reported a significant inverse correlation between serum T3 concentrations and the severity of liver dysfunction as well as a progressive T3 increase in those subjects eventually displaying a favourable outcome, suggesting that T3 concentrations in patients with advanced liver disease may be considered as a helpful prognostic indicator. Moreover, we have found a good correlation between T3 concentrations and serum albumin, bilirubin, and prothrombin-time, while no correlation has been found with the hepatic inflammatory indices like the transaminases and y globulins. These results suggest that T3 concentrations should be considered a sensitive index of hepatic function in liver disease. Only little data have been previously reported on direct measurement of free thyroid hormones in liver patients. Green et al3 found normal FT3 and FIT4 in a small group of cirrhotic patients while low FT4 and normal FT3 concentrations were present in alcoholic fatty liver. Many studies performed with equilibrium dialysis, however, showed decreased FT3 and normal or frequently increased FT4 concentrations.2 18 These findings are confirmed by the present study with direct radioimmunoassay of FT3 and FIT4, both in cirrhotics and in chronic hepatitis patients, although showing more severe abnormalities, especially lower FT3 concentrations in the former group. These data suggest that in chronic liver disease euthyroidism is maintained by a subtle equilibrium between low FT3 and raised FT4 concentrations. The reason for the discrepancy between normal total T4 and increased FT4 concentrations in liver disease is unclear. The finding of increased, rather than decreased, thyroxine binding globulin serum concentration in our patients, in agreement with other reports, 19 20 as well as the finding of a reduced T4/thyroxine binding globulin ratio with an increased FT4 concentration is in agreement with previous suggestions for the presence of a circulating inhibitor (perhaps a IgM molecule) of T4 binding to thyroxine binding globulin in non-thyroidal illnesses including liver cirrhosis. 7 8 Although we have found a significant correlation between T4/thyroxine binding globulin ratio and FT4 in our patients, the correlation coefficient was significantly lower than in normal controls, a finding compatible with the above hypothesis. Slightly increased serum thyrotropin concentration in liver cirrhosis has been previously reported,2 3 but the possibility that this finding indicates the existence of hypothyroidism is unlikely in view of the normal or even reduced thyrotropin response to thyrotropin releasing hormone, a finding confirmed in the present investigation. More likely, the abnormalities in thyrotropin secretion reflect the existence of hypothalamic-pituitary dysfunction in advanced liver disease. In particular, several lines of evidence suggest a reduced dopaminergic tone as a consequence of the accumulation of false neurotransmitters,21 22 which might be responsible for raised basal thyrotropin concentrations, as dopamine has been shown to exert an inhibitory effect in the regulation of thyrotropin 23 secretion. 3 True evidence for hypothyroidism, albeit at a preclinical stage, as suggested by clearly raised thyrotropin concentrations and increased thyrotropin releasing hormone response, has been only found in one patient of the present series, who was affected with Hashimoto's thyroiditis and severe alcoholic hepatitis. Only one of the other 54 patients with either liver cirrhosis or chronic hepatitis had high titres of thyroglobulin antibodies suggesting Hashimoto's thyroiditis, while this disease is relatively frequent in primary biliary cirrhosis and in autoimmune hepatitis.24 In this connection it is to be pointed out that none of these two patients had positive tests for antinuclear, antismooth muscle and antimithocondrial antibodies.
In conclusion, the present investigation, in which thyroid function has been evaluated with all the clinically available indices, confirms the existence of several abnormalities in thyroid function tests in chronic liver disease, although showing that euthyroidism is maintained virtually in all patients, probably as a result of low-normal FT3 and highnormal FT4. Furthermore, T3 serum concentrations appear to parallel the severity of liver dysfunction. 
